Pulmonx Corporation
LUNG
$1.62
-$0.01-0.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.01% | -5.02% | -9.66% | 6.85% | 7.71% |
| Total Depreciation and Amortization | -17.73% | 7.55% | -5.44% | -21.81% | -6.00% |
| Total Amortization of Deferred Charges | 7.69% | 18.18% | -99.36% | 15,609.09% | -21.43% |
| Total Other Non-Cash Items | -9.91% | 9.90% | 57.40% | -36.13% | -27.33% |
| Change in Net Operating Assets | -102.74% | 197.57% | -706.21% | -4.36% | -37.12% |
| Cash from Operations | -108.85% | 70.44% | -96.46% | 7.07% | -25.51% |
| Capital Expenditure | -81.63% | 83.72% | -171.17% | 73.32% | 11.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 59.42% | -66.78% | 17.18% | 97.82% | 2,058.20% |
| Cash from Investing | 59.22% | -66.46% | 15.97% | 108.37% | 908.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 97.92% | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 632.14% | -95.78% | 498.20% | -75.82% | 1,812.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 51.06% | -- | -- | -- | -- |
| Cash from Financing | 370.15% | -110.09% | 970.97% | -86.49% | 2,186.36% |
| Foreign Exchange rate Adjustments | 160.89% | -455.24% | -154.40% | 262.18% | -158.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.84% | -74.99% | -51.92% | 5,127.81% | 97.74% |